IMF Videos Search Content For Care Partner (351) Patient (347) Healthcare Provider (213) Healthcare Professional (210) Series - Any - About the IMF (2) ASCO/EHA (71) ASH (102) Ask Dr. Durie (149) Black Swan Research Initiative (7) Community Workshops (5) Emerging Therapies (18) Facebook Live (21) Health Equity (14) IMF History (3) IMWG (12) Inspirational (15) Living Well with Myeloma (33) Myeloma in a Minute (22) Myeloma Made Simple (15) Myeloma University (12) NLB Webcasts (1) Patient & Family Webinar (11) Q&A (21) Recent News and Developments (5) Treatments (3) Trending Searches in Myeloma (4) Topics Clinical Trials (185) Financial Considerations (15) Frontline Therapy (83) Health Equity (34) Inspirational Stories (23) Insurance (6) Lab & Imaging Tests (69) Lifestyle (47) Mental & Emotional Health (28) Myeloma 101 (56) Myeloma in the News (7) Public Policy & Advocacy (17) Q&A's (42) Recorded Seminars & Workshops (15) Recorded Webinars (24) Relapse/Refractory Myeloma (136) Research Updates (193) Symptom Management (114) Myeloma Stage Early Relapse (1–3 Lines of Therapy) (147) High-Risk Myeloma (96) High-risk Smoldering Myeloma (70) Late Relapse (4–6 Lines of Therapy) (158) MGUS (85) Newly Diagnosed (Pre-Treatment or First Treatment) (158) Smoldering Myeloma (109) Types of Therapy Immunomodulatory drugs (IMiDs) (94) Immunotherapies (CAR T; BiTE, etc.) (161) Monoclonal antibodies (78) Proteasome inhibitors (66) Stem cell transplant (84) Steroids (63) Supportive Care (152) Year Published 2026 (44) 2025 (107) 2024 (93) 2023 (92) 2022 (36) 2021 (31) 2020 (13) 2019 (36) 2018 (21) 2017 (30) 2016 (24) 2015 (30) Trusted Voices Dr. Brian GM Durie (144) Dr. Joseph Mikhael (103) Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO (29) Dr. María-Victoria Mateos (7) Donna Catamero, ANP-BC, OCN, CCRC (5) Dr. Saad Usmani (4) Dr. Sigurður Kristinsson (4) Dr. Urvi A. Shah (4) Dr. Shaji Kumar (3) Dr. S. Vincent Rajkumar (1) Dr. Sagar Lonial (1) Dr. Tom Martin (1) Heather Cooper Ortner (1) Sort Newest firstOldest firstA -> ZZ -> ARelevance Monoclonal Gammopathy of Undetermined Significance and COVID-19: Results from iStopMM December 22, 2021 ASH Estimating Selection Bias in Previous MGUS Research – the Importance of Screening: Results from the Population-Based Screening Study iStopMM December 20, 2021 ASH Are MGUS patients at higher risk of getting severely ill from COVID-19? December 16, 2021 Ask Dr. Durie Global Treatment Patterns and Outcomes Among Patients with Chromosome Translocation (11;14)-Positive Multiple Myeloma December 15, 2021 ASH Defining New Reference Intervals for Serum Free Light Chains in Individuals with Reduced Kidney Function: Results of the Population- Based on iStopMM Study December 15, 2021 ASH Prevalence of Smoldering Multiple Myeloma: Results from the iStopMM Study December 15, 2021 ASH High Prevalence of Monoclonal Gammopathy in a Population at Risk: The First Results of the PROMISE Study December 13, 2021 ASH Assessment of Treatment Response By Ife, Next Generation Flow Cytometry and Mass Spectrometry Coupled with Liquid Chromatography in the GEM2012MENOS65 Clinical Trial December 13, 2021 ASH IMWG Conference Series: ASH 2021 December 13, 2021 IMWG How important are the four iStopMM abstracts being presented at ASH for myeloma patients? December 8, 2021 Ask Dr. Durie M-Power Atlanta Community Workshop November 16, 2021 Health Equity Questions About Multiple Myeloma? November 11, 2021 Inspirational Load More
